Request for Covid-19 Impact Assessment of this Report
The regional analysis of global Nicotine Replacement Therapy market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to increase in habit of cigarette smoking among adults and high availability of products of nicotine replacement therapy. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2027. Factors such as high competition among tobacco companies and increasing demand for such products would create lucrative growth prospects for the Nicotine Replacement Therapy market across Asia-Pacific region.
Major market player included in this report are:
Cipla Inc.
Pfizer, Inc.
GLENMARK
Fertin Pharma
Philip Morris Products S.A.
British American Tobacco p.l.c.
Japan Tobacco, Inc.
Imperial Brands
Johnson & Johnson Services, Inc.
McNeil AB
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
Nicotine Replacement Therapy
• Inhalers
• Gum
• Transdermal Patches
• Sublingual Tablets
• Lozenges
• Others
E-cigarettes
Heat-not-burn tobacco products
By Distribution Channel:
Online
Offline
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2017, 2018
Base year – 2019
Forecast period – 2020 to 2027
Target Audience of the Global Nicotine Replacement Therapy Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
1.2.1. Nicotine Replacement Therapy Market, by Region, 2018-2027 (USD Billion)
1.2.2. Nicotine Replacement Therapy Market, by Product, 2018-2027 (USD Billion)
1.2.3. Nicotine Replacement Therapy Market, by Distribution Channel, 2018-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Nicotine Replacement Therapy Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Nicotine Replacement Therapy Market Dynamics
3.1. Nicotine Replacement Therapy Market Impact Analysis (2018-2027)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Nicotine Replacement Therapy Market: Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2017-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economic
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Nicotine Replacement Therapy Market, by Product
5.1. Market Snapshot
5.2. Global Nicotine Replacement Therapy Market by Product, Performance - Potential Analysis
5.3. Global Nicotine Replacement Therapy Market Estimates & Forecasts by Product 2017-2027 (USD Billion)
5.4. Nicotine Replacement Therapy Market, Sub Segment Analysis
5.4.1. Nicotine Replacement Therapy
5.4.2. E-cigarettes
5.4.3. Heat-not-burn tobacco products
Chapter 6. Global Nicotine Replacement Therapy Market, by Distribution Channel
6.1. Market Snapshot
6.2. Global Nicotine Replacement Therapy Market by Distribution Channel, Performance - Potential Analysis
6.3. Global Nicotine Replacement Therapy Market Estimates & Forecasts by Distribution Channel 2017-2027 (USD Billion)
6.4. Nicotine Replacement Therapy Market, Sub Segment Analysis
6.4.1. Online
6.4.2. Offline
Chapter 7. Global Nicotine Replacement Therapy Market, Regional Analysis
7.1. Nicotine Replacement Therapy Market, Regional Market Snapshot
7.2. North America Nicotine Replacement Therapy Market
7.2.1. U.S. Nicotine Replacement Therapy Market
7.2.1.1. Product breakdown estimates & forecasts, 2017-2027
7.2.1.2. Distribution Channel breakdown estimates & forecasts, 2017-2027
7.2.1.3. Form breakdown estimates & forecasts, 2017-2027
7.2.1.4. Farm Product breakdown estimates & forecasts, 2017-2027
7.2.2. Canada Nicotine Replacement Therapy Market
7.3. Europe Nicotine Replacement Therapy Market Snapshot
7.3.1. U.K. Nicotine Replacement Therapy Market
7.3.2. Germany Nicotine Replacement Therapy Market
7.3.3. France Nicotine Replacement Therapy Market
7.3.4. Spain Nicotine Replacement Therapy Market
7.3.5. Italy Nicotine Replacement Therapy Market
7.3.6. Rest of Europe Nicotine Replacement Therapy Market
7.4. Asia-Pacific Nicotine Replacement Therapy Market Snapshot
7.4.1. China Nicotine Replacement Therapy Market
7.4.2. India Nicotine Replacement Therapy Market
7.4.3. Japan Nicotine Replacement Therapy Market
7.4.4. Australia Nicotine Replacement Therapy Market
7.4.5. South Korea Nicotine Replacement Therapy Market
7.4.6. Rest of Asia Pacific Nicotine Replacement Therapy Market
7.5. Latin America Nicotine Replacement Therapy Market Snapshot
7.5.1. Brazil Nicotine Replacement Therapy Market
7.5.2. Mexico Nicotine Replacement Therapy Market
7.6. Rest of The World Nicotine Replacement Therapy Market
Chapter 8. Competitive Intelligence
8.1. Top Market Strategies
8.2. Company Profiles
8.2.1. Cipla Inc.
8.2.1.1. Key Information
8.2.1.2. Overview
8.2.1.3. Financial (Subject to Data Availability)
8.2.1.4. Product Summary
8.2.1.5. Recent Developments
8.2.2. Pfizer, Inc.
8.2.3. GLENMARK
8.2.4. Fertin Pharma
8.2.5. Philip Morris Products S.A.
8.2.6. British American Tobacco p.l.c.
8.2.7. Japan Tobacco, Inc.
8.2.8. Imperial Brands
8.2.9. Johnson & Johnson Services, Inc.
8.2.10. McNeil AB
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption
TABLE 1. Global Nicotine Replacement Therapy market, report scope
TABLE 2. Global Nicotine Replacement Therapy market estimates & forecasts by Region 2017-2027 (USD Billion)
TABLE 3. Global Nicotine Replacement Therapy market estimates & forecasts by Product 2017-2027 (USD Billion)
TABLE 4. Global Nicotine Replacement Therapy market estimates & forecasts by Distribution Channel 2017-2027 (USD Billion)
TABLE 5. Global Nicotine Replacement Therapy market estimates & forecasts by Form 2017-2027 (USD Billion)
TABLE 6. Global Nicotine Replacement Therapy market estimates & forecasts by Farm Product 2017-2027 (USD Billion)
TABLE 7. Global Nicotine Replacement Therapy market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 8. Global Nicotine Replacement Therapy market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 9. Global Nicotine Replacement Therapy market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 10. Global Nicotine Replacement Therapy market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 11. Global Nicotine Replacement Therapy market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 12. Global Nicotine Replacement Therapy market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 13. Global Nicotine Replacement Therapy market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 14. Global Nicotine Replacement Therapy market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 15. Global Nicotine Replacement Therapy market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 16. Global Nicotine Replacement Therapy market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 17. U.S. Nicotine Replacement Therapy market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 18. U.S. Nicotine Replacement Therapy market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 19. U.S. Nicotine Replacement Therapy market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 20. Canada Nicotine Replacement Therapy market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 21. Canada Nicotine Replacement Therapy market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 22. Canada Nicotine Replacement Therapy market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 23. UK Nicotine Replacement Therapy market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 24. UK Nicotine Replacement Therapy market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 25. UK Nicotine Replacement Therapy market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 26. Germany Nicotine Replacement Therapy market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 27. Germany Nicotine Replacement Therapy market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 28. Germany Nicotine Replacement Therapy market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 29. RoE Nicotine Replacement Therapy market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 30. RoE Nicotine Replacement Therapy market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 31. RoE Nicotine Replacement Therapy market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 32. China Nicotine Replacement Therapy market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 33. China Nicotine Replacement Therapy market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 34. China Nicotine Replacement Therapy market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 35. India Nicotine Replacement Therapy market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 36. India Nicotine Replacement Therapy market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 37. India Nicotine Replacement Therapy market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 38. Japan Nicotine Replacement Therapy market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 39. Japan Nicotine Replacement Therapy market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 40. Japan Nicotine Replacement Therapy market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 41. RoAPAC Nicotine Replacement Therapy market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 42. RoAPAC Nicotine Replacement Therapy market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 43. RoAPAC Nicotine Replacement Therapy market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 44. Brazil Nicotine Replacement Therapy market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 45. Brazil Nicotine Replacement Therapy market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 46. Brazil Nicotine Replacement Therapy market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 47. Mexico Nicotine Replacement Therapy market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 48. Mexico Nicotine Replacement Therapy market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 49. Mexico Nicotine Replacement Therapy market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 50. RoLA Nicotine Replacement Therapy market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 51. RoLA Nicotine Replacement Therapy market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 52. RoLA Nicotine Replacement Therapy market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 53. Row Nicotine Replacement Therapy market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 54. Row Nicotine Replacement Therapy market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 55. Row Nicotine Replacement Therapy market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 56. List of secondary sources, used in the study of global Nicotine Replacement Therapy market
TABLE 57. List of primary sources, used in the study of global Nicotine Replacement Therapy market
TABLE 58. Years considered for the study
TABLE 59. Exchange rates considered
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...